Sputnik Light gets emergency use nod in Philippines

Published On 2021-08-23 04:30 GMT   |   Update On 2021-08-23 04:30 GMT

Manila: The Philippines has approved the emergency use of Russia's Sputnik Light COVID-19 vaccine, the country's vaccine procurement chief said on Monday, making it among the first countries in Asia to approve the single-dose vaccine.The approval by the Philippines' food and drug agency will allow the country to follow up its order for 10 million doses, Carlito Galvez, a retired general...

Login or Register to read the full article

Manila: The Philippines has approved the emergency use of Russia's Sputnik Light COVID-19 vaccine, the country's vaccine procurement chief said on Monday, making it among the first countries in Asia to approve the single-dose vaccine.

The approval by the Philippines' food and drug agency will allow the country to follow up its order for 10 million doses, Carlito Galvez, a retired general who handles the government's vaccine procurement, told a news conference.

The government expects vaccine manufacturers to increase deliveries in September and October, Galvez said.

Mongolia and Kazakhstan have approved Sputnik Light, developed by Russia's Gamaleya Institute.

Sputnik Light is ninth COVID-19 vaccine approved by the Philippines, along with vaccines from Pfizer, Moderna, Johnson & Johnson and China's Sinovac and Sinopharm.

Read also: RDIF proposes Pfizer conduct joint trials with Sputnik Light as booster shot

Philippine authorities have said the vaccine rollout is key to the recovery of the Southeast Asian country's economy. The Philippines was one of the fastest growing economies in Asia before the pandemic, but contracted by a record 9.6% in 2020.

The Philippines has so far fully vaccinated 17.26 million people, leaving much of its 110 million population vulnerable to the highly contagious Delta variant.

Read also: Wockhardt, RDIF collaborate for producing Sputnik V, Sputnik Light




Tags:    
Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News